Highbridge Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Highbridge Capital Management's PFE Position: Q4 2018 in Review
Highbridge Capital Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 223,057 shares — an estimated $9.33M sold.
Highbridge Capital Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $58M in Q2 2014. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.
- Highbridge Capital Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
- Highbridge Capital Management sold 223,057 Pfizer shares in Q4 2018, an estimated $9.33M.
- Highbridge Capital Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
- Highbridge Capital Management's Pfizer position peaked at $58M in Q2 2014.
- 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.
Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.